Volume 58, Issue 5, Pages (November 2010)

Slides:

Advertisements

Similar presentations

Judith Bosschieter, André N. Vis, Henk G. van der Poel, Luc M

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 70, Issue 5, Pages (November 2016)

Volume 57, Issue 1, Pages (January 2010)

Volume 71, Issue 5, Pages (May 2017)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 52, Issue 3, Pages (September 2007)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 61, Issue 5, Pages (May 2012)

Volume 63, Issue 4, Pages (April 2013)

Lymphadenectomy in the Surgical Management of Penile Cancer

Volume 54, Issue 4, Pages (October 2008)

EAU Guidelines on Testicular Cancer: 2011 Update

Volume 70, Issue 5, Pages (November 2016)

Tet Yap, Nicholas Watkin, Suks Minhas European Urology Supplements

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Volume 63, Issue 4, Pages (April 2013)

Volume 64, Issue 4, Pages (October 2013)

Volume 64, Issue 4, Pages (October 2013)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

Volume 52, Issue 4, Pages (October 2007)

Volume 68, Issue 5, Pages (November 2015)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 73, Issue 3, Pages (March 2018)

Volume 54, Issue 4, Pages (October 2008)

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

The Potential of MicroRNAs as Prostate Cancer Biomarkers

Volume 52, Issue 5, Pages (November 2007)

Volume 52, Issue 3, Pages (September 2007)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 70, Issue 3, Pages (September 2016)

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 56, Issue 2, Pages (August 2009)

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 68, Issue 1, Pages (July 2015)

Volume 63, Issue 5, Pages (May 2013)

Volume 60, Issue 5, Pages (November 2011)

Volume 66, Issue 6, Pages (December 2014)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 72, Issue 1, Pages (July 2017)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 2, Pages (August 2014)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 52, Issue 1, Pages (July 2007)

The Economic Costs of Overactive Bladder in Germany

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad

Volume 74, Issue 6, Pages (December 2018)

Volume 71, Issue 5, Pages (May 2017)

Volume 71, Issue 5, Pages (May 2017)

Volume 74, Issue 5, Pages (November 2018)

Testicular Cancer Variations in Time and Space in Europe

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer Amar U. Kishan, Rahul.

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Volume 54, Issue 3, Pages (September 2008)

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 58, Issue 5, Pages 742-747 (November 2010) Prognostic Factors for Occult Inguinal Lymph Node Involvement in Penile Carcinoma and Assessment of the High-Risk EAU Subgroup: A Two-Institution Analysis of 342 Clinically Node-Negative Patients Niels M. Graafland, Wayne Lam, Joost A.P. Leijte, Tet Yap, Maarten P.W. Gallee, Cathy Corbishley, Erik van Werkhoven, Nick Watkin, Simon Horenblas European Urology Volume 58, Issue 5, Pages 742-747 (November 2010) DOI: 10.1016/j.eururo.2010.08.015 Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 1 Flow diagram of patient inclusion. DSNB=dynamic sentinel node biopsy; cN+=clinically node positive; cN0=clinically node negative; NKI/AVL=Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital; SGH=St. George’s Hospital. European Urology 2010 58, 742-747DOI: (10.1016/j.eururo.2010.08.015) Copyright © 2010 European Association of Urology Terms and Conditions